Panax Ginseng
Also sold as: Panax ginseng · Asian ginseng · Korean red ginseng
An Asian root taken for fatigue, cognition and sexual function; species, processing and extract standardization differ across studies.
Energy Focus Anxiety
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Focus: Heterogeneous cognition studies give inconsistent results; some involve American ginseng, a different species.
- Anxiety: One perceived-stress trial is preliminary and does not establish treatment of clinical anxiety.
- Energy: Disease-related fatigue improved modestly across RCTs; healthy-adult energy and athletic performance remain uncertain.
REALITY CHECK // Ginseng is marketed as coffee-like energy and guaranteed memory enhancement. The strongest clinical signal is a small fatigue improvement in people with illness; cognition, sexual-function and blood-pressure results are less certain. American and Asian ginseng are different species, and trials do not establish a universal extract dose.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // No formal EFSA/NIH UL is indexed; a trial maximum or an uncontrolled high-dose toxicity report is not a safe daily ceiling.
Summary
The clearest signal is disease-related fatigue: 12 RCTs (n=1,298) reported SMD 0.33 (95% CI 0.22–0.44). Most participants had chronic illness or cancer. Cognitive results are heterogeneous; American-ginseng trials cannot be assigned to Panax ginseng. Erectile-function evidence is low or very low certainty. Fasting-glucose changes are small. Blood-pressure meta-analyses conflict, and sustained athletic performance benefits are unestablished.
Mechanism
Ginsenosides are transformed by gut microbes, including conversion to compound K. Species, steaming and microbiota change exposure. Proposed neuroendocrine, immune and vascular effects do not by themselves prove cognitive, anxiety or longevity benefits.
Typical studied dose
The dossier reports approximately 200–3,000 mg/day of root or standardized preparations across studies. These are study ranges, not personal prescriptions; root and extract weights are not interchangeable. Form-specific dose intervals and extraction equivalence are not indexed, so calculator trial comparisons are disabled.
Upper limit
No formal EFSA/NIH upper limit is indexed for Panax ginseng. A short-term safety RCT does not establish a lifetime ceiling. Older uncontrolled reports at prolonged intakes above 3 g/day describe insomnia, nervousness, diarrhoea and increased blood pressure; this is a weak toxicity signal, not a defined threshold.
Popular stacks with Panax Ginseng
Not enough stack data yet. A combination with Panax Ginseng appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Korean red ginseng (steamed Panax ginseng) Best for: Identifying the species and steamed preparation used in a trial. |
Unstandardized: active content unknown | no comparable trial range | Native ginsenosides have low absorption; microbiota convert some to compound K, with substantial individual variation. Generally tolerated; occasional stomach discomfort. |
Caution [SPECIFICATION // CHECK_STUDY_MATCH] Steaming changes the Rg3/Rk1/Rg5 profile. The dossier supplies no preparation-specific dose interval or marker percentage; no numeric trial equivalence is available. |
| White ginseng / dried Panax ginseng root Best for: Identifying unprocessed root material. |
Unstandardized: active content unknown | no comparable trial range | Depends on gut conversion of ginsenosides to compound K. Generally tolerated in short-term use. |
Caution [SPECIFICATION // CHECK_STUDY_MATCH] Root weight is not interchangeable with extract weight. The broad dossier range must not be treated as a verified white-root trial target. |
| Panax ginseng extract standardized to approximately 4% ginsenosides Best for: Matching a declared extract specification to a specific study. |
Extract weight · ~4% marker | no comparable trial range | Standardization improves batch consistency; it does not establish identical absorption across products. Short-term tolerability evaluated in a randomized trial. |
Studied standard [SPECIFICATION // CHECK_STUDY_MATCH] The source lists a G115-type specification, but does not give a verifiable form-specific trial-dose range. Marker content can be displayed; dose equivalence remains unavailable. |
Common label traps
- TRAP_01 // ALL GINSENG IS THE SAME
Panax ginseng, American ginseng and other Panax species have different compositions; trial results cannot automatically cross species. - TRAP_02 // RED ALWAYS BEATS WHITE
Steaming changes ginsenoside composition, but the dossier does not establish universal clinical superiority. - TRAP_03 // GUARANTEED ENERGY, MEMORY AND BLOOD-PRESSURE CONTROL
Disease-related fatigue has the clearest small effect. Cognition is inconsistent, blood-pressure reviews conflict, and healthy-athlete performance is unestablished.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- ERECTILE FUNCTION Limited · benefit
Nine studies (n=587) lasting≤12 weeks provide low/very-low-certainty evidence in men with erectile dysfunction; persistent symptoms need medical assessment.
PMID 33871063 - FASTING GLUCOSE Moderate · benefit
Sixteen trials (n=770) show a small fasting-glucose reduction; HbA1c/insulin results are less consistent and do not justify replacing diabetes treatment.
PMID 25265315 PMID 26871778 - BLOOD PRESSURE Limited · no benefit
A17-study synthesis (n=1,381) was null; a nine-trial synthesis reported acute Korean-red-ginseng reductions (SBP−6.52, DBP−5.21 mmHg). Sustained benefit remains unresolved.
PMID 27074879 PMID 28707603 - RESPIRATORY INFECTIONS Limited · benefit
A systematic review suggests possible reductions in infection frequency/duration, with limited study quality.
PMID 32951718 - EXERCISE / RECOVERY Limited · no benefit
Healthy-athlete performance effects are weak or inconsistent; muscle-damage biomarkers do not prove lasting ergogenic or hypertrophy benefits.
PMID 27822924 PMID 38888561
Reader questions
What dose worked, and how long did studies last?
The dossier combines approximately200–3,000 mg/day across root and extract studies; it does not provide reliable form-specific equivalence. Acute cognition tests, weeks-long fatigue outcomes and≤12-week erectile-function trials answer different questions. The calculator does not recommend a dose.
Are red, white and American ginseng interchangeable?
No. Red and white refer to processing of Asian Panax ginseng; American ginseng is Panax quinquefolius. Check the species and marker specification before comparing a label with a study.
Should it be used before bed or with food?
The supplied data do not establish an optimal timing/food schedule. Insomnia and activation are reported concerns, particularly with caffeine; a suggested schedule is not a proven efficacy protocol.
Does it treat erectile dysfunction?
A Cochrane review of9 studies (n=587) found low or very-low-certainty short-term evidence. It is not an established substitute for treatment, and persistent erectile symptoms deserve medical assessment.
Can it be combined with coffee or diabetes and blood-pressure medicines?
Caffeine may add activation. Glucose-lowering effects can interact with diabetes treatment; blood-pressure evidence conflicts and higher-dose activation is a concern. A pharmacist or clinician should review the specific medicines and preparation.
Stack interactions
- Danger Warfarin / anticoagulation [CAUTION // CLINICAL_REVIEW]
Mixed interaction findings include lower INR or weaker anticoagulation; medical review and INR monitoring are needed.
PMID 18637764 PMID 19913311 PMID 27864798 - Caution Glucose-lowering medicines [CAUTION // CLINICAL_REVIEW]
Small fasting-glucose reductions may add to insulin or other diabetes medicines; do not change prescribed treatment based on a supplement card.
PMID 25265315 - Danger MAO inhibitors [CAUTION // CLINICAL_REVIEW]
Older case reports describe mania, insomnia or headache with combinations; this is a case-report signal, not a quantified RCT risk. - Caution Immunosuppressants [CAUTION // CLINICAL_REVIEW]
Potential immune effects could oppose treatment; the interaction remains theoretical in this dossier. - Caution Caffeine / other stimulants and adaptogens [CAUTION // CLINICAL_REVIEW]
Additive activation, insomnia or blood-pressure/pulse changes are possible. Adaptogen stack benefits and optimal cycling are not established by controlled interaction trials.
Red flags: interactions and who should avoid it
Interactions
Warfarin findings conflict: reduced anticoagulant effect is reported in one study, whereas another found no significant interaction; INR needs clinical review. Glucose-lowering medicines may have additive effects. Older case reports link MAO-inhibitor combinations to activation/mania. Immunosuppressant antagonism is theoretical. Caffeine and other stimulants may add insomnia or agitation.
Avoid or ask a doctor first if
Avoid routine use during pregnancy, breastfeeding or childhood because safety data are insufficient. Seek clinical review with autoimmune disease, immunosuppression, uncontrolled hypertension, insomnia/anxiety, anticoagulant or diabetes treatment, and before surgery. New palpitations, marked agitation or symptoms of hypoglycaemia warrant stopping and medical assessment.
Sources (PubMed, 19)
- Efficacy of ginseng supplements on disease-related fatigue: A systematic review and meta-analysis.
PMID 35776997 · 2022 · Journal Article; Meta-Analysis; Systematic ReviewA meta-analysis of 12 RCTs (n=1,298) reported a small reduction in disease-related fatigue, SMD 0.33 (95% CI 0.22–0.44); this does not establish an effect in healthy athletes.
- Efficacy of Ginseng Supplements on Fatigue and Physical Performance: a Meta-analysis.
PMID 27822924 · 2016 · Journal Article; Meta-AnalysisFatigue and physical-performance meta-analysis: the dossier reports a fatigue signal, with weaker and inconsistent performance findings.
- Effects of Ginseng on Cancer-Related Fatigue: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
PMID 35184068 · 2022 · Meta-Analysis; Systematic Review; Journal ArticleCancer-related fatigue RCT synthesis; findings concern oncology populations rather than ordinary tiredness in healthy adults.
- Effects of Ginseng on Cognitive Function: A Systematic Review and Meta-Analysis.
PMID 39474788 · 2024 · Journal Article; Meta-Analysis; Systematic ReviewCognitive-outcome meta-analysis with heterogeneous preparations and inconsistent findings across cognitive domains.
- Cognitive Benefits of Ginseng: A Systematic Review and Meta-Analysis of Changes in Mini-Mental State Examination and Alzheimer's Disease Assessment Scale-Cognitive Subscale Scores.
PMID 40774237 · 2025 · Journal Article; Systematic Review; Meta-AnalysisCognitive-score meta-analysis; the dossier considers sustained cognitive benefit uncertain and preparation-dependent.
- A randomized, placebo-controlled trial investigating the acute and chronic benefits of American Ginseng (Cereboost®) on mood and cognition in healthy young adults, including in vitro investigation of gut microbiota changes as a possible mechanism of action.
PMID 34396468 · 2022 · Journal Article; Randomized Controlled TrialAcute/chronic cognition and mood trial of American ginseng (Panax quinquefolius), a different species; it cannot establish a Panax ginseng dose.
- Ginseng for erectile dysfunction.
PMID 33871063 · 2021 · Journal Article; Meta-Analysis; Systematic ReviewCochrane review of 9 studies (n=587) in men with erectile dysfunction, lasting no more than 12 weeks; certainty was low or very low.
- The effect of ginseng (the genus panax) on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials.
PMID 25265315 · 2014 · Journal Article; Meta-Analysis; Research Support; Non-U.S. Gov't; Systematic ReviewSixteen trials (n=770) showed a small fasting-glucose reduction; HbA1c and insulin findings were less consistent.
- The Efficacy of Ginseng-Related Therapies in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis.
PMID 26871778 · 2016 · Journal Article; Meta-Analysis; Research Support; Non-U.S. Gov't; Systematic ReviewSystematic review of ginseng-related therapies in type 2 diabetes; the dossier reports modest glucose effects, not a replacement for treatment.
- The effect of ginseng (genus Panax) on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials.
PMID 27074879 · 2016 · Journal Article; Meta-Analysis; Systematic ReviewSeventeen studies (n=1,381) found no significant overall effect on systolic, diastolic or mean arterial pressure.
- Ginseng for Treating Hypertension: A Systematic Review and Meta-Analysis of Double Blind, Randomized, Placebo-Controlled Trials.
PMID 28707603 · 2017 · Journal Article; Meta-Analysis; Systematic ReviewNine-trial synthesis reported an acute Korean-red-ginseng blood-pressure signal, conflicting with the larger null synthesis; species and duration differ.
- Ginseng integrative supplementation for seasonal acute upper respiratory infections: A systematic review and meta-analysis.
PMID 32951718 · 2020 · Journal Article; Meta-Analysis; Systematic ReviewRespiratory-infection systematic review suggests possible prevention or duration effects, with limited study quality.
- Effect of Hydroponically Grown Red Panax Ginseng on Perceived Stress Level, Emotional Processing, and Cognitive Functions in Moderately Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.
PMID 40289951 · 2025 · Journal Article; Randomized Controlled TrialSingle randomized trial in moderately stressed adults provides an early perceived-stress signal, not evidence for treating an anxiety disorder.
- The effect of Panax ginseng supplementation on markers of resistance exercise-induced muscle damage: a systematic review.
PMID 38888561 · 2024 · Journal Article; Systematic ReviewReview of resistance-exercise muscle-damage markers; short-term biomarkers do not demonstrate sustained performance or hypertrophy.
- Safety and tolerability of Panax ginseng root extract: a randomized, placebo-controlled, clinical trial in healthy Korean volunteers.
PMID 22909282 · 2012 · Journal Article; Randomized Controlled Trial; Research Support; Non-U.S. Gov'tRandomized safety/tolerability study of root extract in healthy Korean volunteers; does not establish long-term safety or a formal upper limit.
- Interaction between warfarin and Panax ginseng in ischemic stroke patients.
PMID 18637764 · 2008 · Journal Article; Randomized Controlled Trial; Research Support; Non-U.S. Gov'tWarfarin interaction study in ischemic stroke patients; the dossier reports reduced anticoagulant effect, with mixed evidence across studies.
- Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement.
PMID 19913311 · 2010 · Comparative Study; Letter; Research Support; Non-U.S. Gov'tKorean-red-ginseng/warfarin study in cardiac-valve patients; the dossier reports no significant interaction here, conflicting with other reports.
- Pharmacokinetic Drug Interactions with Panax ginseng.
PMID 27864798 · 2017 · Journal Article; ReviewPharmacokinetic interaction review; drug interactions require preparation-specific assessment.
- Interactions between herbal medicines and prescribed drugs: an updated systematic review.
PMID 19719333 · 2009 · Journal Article; Systematic ReviewSystematic review of herbal medicine–prescription drug interactions, used for the dossier safety context.
Community comments
No approved comments yet. Comments are held for moderation.